Target intelligence / Profile preview

TFIP11 divergent transcript (TFIP11-DT)

Target
TFIP11-DT
Molecular classification
Other (non-coding RNA transcript, possibly long noncoding RNA/lncRNA, divergent transcript)
01

Overview

TFIP11 divergent transcript (TFIP11-DT, CTA-445C9.14) is an annotated transcript at the TFIP11 gene locus, presumed to be a non-coding RNA generated through divergent transcription, a process whereby RNAs are transcribed in the antisense direction from gene promoters and enhancer regions. TFIP11 encodes a spliceosomal protein involved in intron release during mRNA splicing, but TFIP11-DT itself has not been functionally characterized and is not an established therapeutic target. The presence of a divergent transcript in the TFIP11 region is consistent with common genomic features observed in mammals, where such RNAs arise without strong TATA elements at CpG-rich promoters and enhancers; these transcripts are often non-coding, and their function may relate to gene origination or regulatory processes, although this has not been demonstrated for TFIP11-DT specifically. Important Note: If TFIP11-DT is meant to refer to a better-characterized molecule or if specific transcript information (such as annotation in major databases like Ensembl or RefSeq) is intended, more precise nomenclature or database identifiers are needed. Currently, it is not recognized as a well-defined molecular target in therapeutic discovery.

Other names
CTA-445C9.14TFIP11-DT
02

Mechanism of action

None

03

Biological functions

Other (no specific biological function is characterized for TFIP11-DT; divergent transcripts in general may play a role in gene regulation, chromatin remodeling, or serve as sources for new gene origination)
04

Disease associations

Other (no clearly established role in disease for TFIP11-DT; TFIP11 gene mutations are associated with dental caries and dentine erosion, but no evidence links TFIP11-DT to defined pathology)
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on TFIP11 divergent transcript (TFIP11-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TFIP11 divergent transcript (TFIP11-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call